1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,263 | 0,325 | 11:11 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.07. | Neem's Hill AB: Scandinavian ChemoTech AB changes name to Neem's Hill AB | 212 | GlobeNewswire (Europe) | Former Scandinavian ChemoTech AB, has completed the name change to Neem's Hill AB ("Neem's Hill" or "the Company"), which was resolved at the Annual General Meeting held on 5 May 2026. The name change... ► Artikel lesen | |
| 10.07. | Change of issuer name for Scandinavian ChemoTech AB | 286 | GlobeNewswire | As from July 13, 2026, Scandinavian ChemoTech AB will change issuer name
Company name is Neem's Hill AB.
Old issuer name: Scandinavian ChemoTech AB
New issuer name: Neem's Hill AB
New... ► Artikel lesen | |
| 02.06. | Scandinavian ChemoTech AB: Scandinavian ChemoTech secures SEK 6 million Growth Loan from a larger Swedish Financial Institution | 145 | GlobeNewswire (Europe) | Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden.
The financing forms part of ChemoTech's long-term financial strategy and will support the... ► Artikel lesen | |
| 28.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim report Q1 2026 | 259 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website January - March 2026
Net sales amounted to 2,798 KSEK (2,472)
Profit/loss after... ► Artikel lesen | |
| 07.04. | Scandinavian ChemoTech AB: ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North | 180 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) (the "Company") today announces that, based on information disclosed in the Company's press releases published on Tuesday, March 31, ahead of the notice of the Annual... ► Artikel lesen | |
| 01.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History | 198 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care continues its strong commercial momentum, delivering its best first quarter in the company's history in Q1 2026, with sales amounting to approx. 299,000 USD compared... ► Artikel lesen | |
| 31.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech proposes expanded business activities, name change & received proposal on directed issue | 256 | GlobeNewswire (Europe) | NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND... ► Artikel lesen | |
| 17.02. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-end report 2025 | 270 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
October - December 2025
Net sales amounted to 2,648 KSEK (2,041)
Profit/loss after... ► Artikel lesen | |
| NEEMS HILL Aktie jetzt für 0€ handeln | |||||
| 05.01. | Scandinavian ChemoTech AB: New Year's Letter to Shareholders in Scandinavian ChemoTech - Reflecting on 2025 | 361 | GlobeNewswire (Europe) | Dear Shareholders,
As we enter 2026, I would like to thank you for your continued trust and support of Scandinavian ChemoTech. The past year, 2025, has been an important one for the Company, a year... ► Artikel lesen | |
| 04.11.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 226 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen | |
| 17.10.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 243 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen | |
| 01.10.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown | 265 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking... ► Artikel lesen | |
| 26.09.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion | 614 | GlobeNewswire (Europe) | Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland.... ► Artikel lesen | |
| 10.09.25 | Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology | 220 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the... ► Artikel lesen | |
| 12.08.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025 | 278 | GlobeNewswire (Europe) | Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 71,98 | 0,00 % | BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy? | ||
| ALIGNMENT HEALTHCARE | 18,650 | -0,11 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| ADAPTHEALTH | 10,960 | 0,00 % | Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln Total | WASHINGTON (dpa-AFX) - Healthcare services company Cardinal Health, Inc. (CAH) announced late Monday its agreement to acquire the Diabetes Health business of AdaptHealth Corp. (AHCO), as well... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,130 | -1,71 % | FMC: Analysten sehen Abwärtspotenzial | Am 4. August wird Fresenius Medical Care, kurz FMC, die Zahlen zum zweiten Quartal vorstellen. Die Analysten der Deutschen Bank rechnen mit einem organischen Umsatzplus von 3 Prozent. Deutlicher soll... ► Artikel lesen | |
| BILLIONTOONE | 127,77 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 35,310 | -0,70 % | Warum der Wolfram-Engpass SpaceX und Siemens Healthineers bedroht und wie Almonty zur ersten Adresse des Westens wird | Wenn technische Notwendigkeit auf Knappheit trifft, werden nicht nur Ingenieure hellhörig - auch der Kapitalmarkt setzt sich längst mit Lieferketten und deren Krisenanfälligkeit auseinander. Besonders... ► Artikel lesen | |
| GENEDX | 60,58 | 0,00 % | NSE - GeneDx Holdings Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| HEARTFLOW | 25,360 | 0,00 % | Heartflow, Inc.: Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026 | ||
| AVEANNA HEALTHCARE | 9,665 | -0,05 % | Aveanna Healthcare (AVAH) Just Flashed Golden Cross Signal: Do You Buy? | ||
| PROGYNY | 31,620 | +0,10 % | Barclays downgrades Progyny stock rating on utilization concerns | ||
| PROCEPT BIOROBOTICS | 17,700 | +0,06 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,680 | +0,04 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| FRESENIUS | 44,010 | -0,54 % | Fresenius: Analystenlob sorgt für neuen Schwung - Trading-Tipp des Tages | Die Aktie von Fresenius hat nach einer weitestgehend enttäuschenden ersten Jahreshälfte 2026 ab Juni wieder Fahrt aufgenommen. Nach einem kleinen Rücksetzer sorgen die Analysten der Deutschen Bank für... ► Artikel lesen | |
| MIMEDX | 4,260 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Launch of G4Derm Plus | Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx... ► Artikel lesen | |
| RXSIGHT | 5,640 | 0,00 % | RxSight, Inc.: RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules |
Das Unternehmen NEEMS HILL AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,257 Euro und damit +11,26 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEEMS HILL AB finden Sie auf Wallstreet Online.